- Nuclear imaging devices are medical imaging equipment that use radioactive materials to diagnose the severity of disorders such as cardiovascular disease, cancer, gastrointestinal, endocrine, neurological, and other brain problems
- These non-invasive devices offer operational data at the molecular and cellular levels, allowing doctors to diagnose and assess medical issues
- U.S. is expected to dominate the nuclear imaging devices market with 34.3% due to its advanced healthcare infrastructure, high healthcare expenditure, and a substantial patient base requiring diagnostic imaging
- Canada is expected to be the fastest growing region in the nuclear imaging devices market during the forecast period due to increasing healthcare investments and technological advancements
- The single photon emission computed tomography (SPECT) segment is expected to dominate the market with a market share with 57.2% due to cost-effectiveness associated with SPECT equipment and procedures
Frequently Asked Questions
U.S. is expected to dominate the North America nuclear imaging devices market with 34.3%, particularly in the North America region. This dominance is attributed to its advanced healthcare infrastructure, high healthcare expenditure, and a substantial patient base requiring diagnostic imaging.
Canada is expected to witness the highest CAGR in the nuclear imaging devices market. This growth is driven by increasing healthcare investments and technological advancements.
The single photon emission computed tomography (SPECT) segment is expected to dominate the North America nuclear imaging devices market holding a major market share with 57.2% in 2025, due to its cost-effectiveness associated with SPECT equipment and procedures.
